Versant Venture Capital VII, L.P.

Insider Reports History

Entity
Company
Location
One Sansome Street, Suite 1650, San Francisco, CA
Signature
Versant Venture Capital VII, L.P. By: Versant Ventures VII GP, L.P. Its: General Partner By: Versant Ventures VII GP-GP, LLC By: /s/ Max Eisenberg Its: Chief Operating Officer
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Versant Venture Capital VII, L.P.:

Stock Role Class Num Shares Value Price $ Report Date Ownership
CHINOOK THERAPEUTICS, INC. 10%+ Owner Common Stock 2.91M $114M $39.03 Apr 4, 2022 Direct
LENZ Therapeutics, Inc. 10%+ Owner Common Stock 1.6M $6.52M $4.08 Mar 21, 2024 Direct
CHINOOK THERAPEUTICS, INC. 10%+ Owner Common Stock 0 $39.03 Apr 4, 2022 Indirect

Insider Reports Filed by Versant Venture Capital VII, L.P.

Symbol Company Period Transactions Value $ Form Type Date Filed Role
LENZ LENZ Therapeutics, Inc. Mar 21, 2024 0 $0 3 Mar 25, 2024 10%+ Owner
KDNY CHINOOK THERAPEUTICS, INC. Apr 4, 2022 5 $0 4 Apr 6, 2022 10%+ Owner
KDNY CHINOOK THERAPEUTICS, INC. Jan 3, 2022 3 -$16M 4 Jan 5, 2022 10%+ Owner
KDNY CHINOOK THERAPEUTICS, INC. Aug 27, 2021 3 -$11.9M 4 Aug 31, 2021 10%+ Owner